Side-by-side comparison of AI visibility scores, market position, and capabilities
FRA-approved commercial pilot launched in Georgia. $100M+ total funding. 300+ vehicles on backlog. Commercial revenue expected in 2026. Battery-electric autonomous railcars.
Parallel Systems is the only startup with Federal Railroad Administration (FRA) approval to run autonomous battery-electric railcars on active commercial rail networks. The FRA approval — which took years to obtain — is a regulatory moat that no competitor has replicated. Parallel's commercial pilot, launched in Georgia in 2025, is generating real operational data on active freight rail and building the safety record needed for broader commercial deployment.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.